Melinda Taschetta-Millane, Editorial Director
Melinda Taschetta-Millane, Editorial Director
Blog | Melinda Taschetta-Millane, Editorial Director | Proton Therapy | September 08, 2017

The Future of Medical Imaging

associate editor Jeff Zagoudis had the opportunity to interview AHRA President Jason Newmark, CRA, FAHRA, and CEO Ed Cronin.

You can watch Jeff’s entire interview with Newman and Cronin at http://bit.ly/2vI4kMc.

The ITN team recently attended the Association for Medical Imaging Management (AHRA)’s 45th Annual Meeting and Exposition in Anaheim, Calif., where nearly 1,000 members, vendors and presenters came together to learn and network. We learned from the three nationally renowned keynote speakers, more than 100 breakout sessions and from the new technology showcased in the exhibit hall by 160 different companies.

At the meeting, associate editor Jeff Zagoudis had the opportunity to interview AHRA President Jason Newmark, CRA, FAHRA, and CEO Ed Cronin. Newmark and Cronin highlighted the association’s accomplishments over the past year, and discussed how AHRA will help its members face the coming changes in healthcare.

Highlighting what is new, Newmark mentioned that regulatory affairs are a huge issue for AHRA, its members and all of the regulations that are coming down the pipeline. “We decided a few years ago that we need to be a little more active in that area, so we created the Regulatory Affairs committee, and they are charged initially with just monitoring what is happening, and develop position papers so our members would understand what was coming down and what they should be focusing on,” he explained. “But we found after we started to do that that we could probably have more input into the decision-making process, so we are now more active in advocating for outcomes rather than just monitoring and informing our members, so I think that will be something that we really will be focusing on in the future.”

The AHRA Education Foundation (EF) launched a new campaign at this year’s meeting. “We are calling it ‘Defining Our Future,’ and it’s going to focus on developing leadership skills for the next generation, developing education programs for our members so they continue to excel at what they do, a lot of research, and also expanding our advocacy programs,” said Newmark.

The association plans to continue to grow its membership, and according to Newmark, is going back to the grassroots. “We are having our members around the country host local meetings where we can get our members in that area to come together, and also invite nonmembers,” he stated.

You can watch Jeff’s entire interview with Newman and Cronin at http://bit.ly/2vI4kMc, in addition to other videos, including Personalized Breast Screening and Breast Density with Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy; Critical Issues in Radiology Administration featuring Angelic McDonald, MSRS, CRA, FAHRA, regional director of imaging, Baylor Scott & White Health and the president-elect of AHRA; and The Role of Analytics in Value-Based Healthcare with Woojin Kim, M.D., chief medical information officer, Nuance Communications. These videos, along with other show coverage, can be found at http://bit.ly/2vSq07Z.

Related Content

News | Proton Therapy | June 16, 2020
June 17, 2020 — RaySearch Laboratories AB launched the latest release of its widely adopted treatment planning system
Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Feature | Proton Therapy | May 27, 2020 | By Minesh Mehta, M.D.
Radiation therapy has advanced significantly in the last few decades as a result of a continued technological revolut
The global radiation therapy market is expected to reach $10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.
News | Proton Therapy | May 20, 2020
May 20, 2020 — ResearchAndMarkets.com has released its latest report, the ...
Due to ongoing health concerns related to the spread of the Coronavirus (COVID-19) as well as global travel restrictions, the American Association of Physicists in Medicine (AAPM) has decided to evolve the Joint AAPM/COMP (Canadian Organization of Medical Physicists) Meeting content into a virtual (completely online) meeting in place of the in-person meeting originally scheduled for July 12-16, 2020, in Vancouver, BC.
News | AAPM | May 11, 2020
May 11, 2020 — Due to ongoing health concerns related to the spread of the Coronavirus (...
Eclipse v16 has received CE mark and is 510(k) pending
News | Proton Therapy | April 06, 2020
April 6, 2020 — Driven by its Intelligent Cancer Care approach in developing new solutions that use advanced technolo
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
Rising concerns over radiation overexposure teamed with a growing focus on improving the quality of patient care are two key drivers of today’s radiation dose management market. 

Rising concerns over radiation overexposure teamed with a growing focus on improving the quality of patient care are two key drivers of today’s radiation dose management market. 

Feature | Radiation Dose Management | April 02, 2020 | By Melinda Taschetta-Millane
Rising concerns over...
The radiation therapy market is projected to grow in through 2026

Image courtesy of Accuray

News | Proton Therapy | February 10, 2020
February 10, 2020 — Amid technological advancement, and notable research and development activities, the global ...
IBA ProteusOne proton therapy system
News | Proton Therapy | January 29, 2020
January 29, 2020 — IBA (Ion Beam Applications S.A.) announced that it has signed a contract and received a major down